Biocon Biologics’ partner receives positive EU CHMP opinion for biosimilar human insulin for IV infusion
Celerity Pharmaceuticals uses Biocon Biologics’ insulin drug substance to develop the product
Celerity Pharmaceuticals uses Biocon Biologics’ insulin drug substance to develop the product
Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies
Through this partnership, Premas will connect with genomics labs to provide automated NGS solutions
The plant is scheduled to come on stream in September 2024
The new structure further transitions the Health Care business line into a system solutions partner for the pharmaceutical and biotech industries
No new studies have been requested
BVX-0922 to target colorectal cancer under investigator-sponsored IND
Air purification system achieves Intertek zero ozone certification
A major unresolved question in the field, however, is how do this machinery rapidly searches for and finds rare stretches of damage amid the "vast fields" of undamaged DNA
The event will have a mix of policymakers, national and international leaders from the pharma industry, MSME, innovators, academic and research fraternity
Subscribe To Our Newsletter & Stay Updated